http://rdf.ncbi.nlm.nih.gov/pubchem/patent/WO-2010032113-A3
Outgoing Links
| Predicate | Object |
|---|---|
| assignee | http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_142b55fe12afec6793919c0c81d54f6d http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_89d98da599a7fb715284473aee477c77 http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_b05f30b23dac1425278f853ce6c80fea http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_f9b5c148453e6e5cc6ac6a97067f8051 http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_343901af398cc67330138a959b6d21e8 |
| classificationCPCInventive | http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P33-00 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K47-32 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P33-10 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K9-0056 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K9-0095 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K31-7048 |
| classificationIPCInventive | http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P33-10 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K9-00 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-7048 |
| filingDate | 2009-08-28-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| inventor | http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_df3157804542eb9f3f650b123f7a1fbc http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_e10205451e6f0429b4f740ae46bb46a1 http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_00baf6c5b2fa7d1d16cb94917eba9624 http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_d598d06920d4a307466e11113ea50bcd |
| publicationDate | 2010-06-17-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| publicationNumber | WO-2010032113-A3 |
| titleOfInvention | Composition and use of a long-acting oral bioadhesive endoparasiticide gel based on doramectin |
| abstract | The present invention relates to the composition of an oral bioadhesive endoparasiticide gel based on doramectin, having a high degree of adhesion to equine oral mucosa and having a sweet flavour greatly facilitating the dosing thereof, procedures for the preparation and the utilisation thereof. Gastrointestinal helminthosis is a parasitic condition caused by nematodes of diverse families occasioning serious gastrointestinal disorders in equine livestock. Control of this illness is of great importance and advantageously achievable through the employment of appropriate antihelminthic agents such as doramectin, being a chemical compound widely administered by parenteral route and infrequently by oral route in liquid form due to the organoleptic and physicochemical characteristics of the compositions known up to the present. The present invention demonstrates that it is possible to administer doramectin in the pharmaceutical form of an oral gel at concentrations of up to 5.0% weight/volume, overcoming the organoleptic and physicochemical restrictions of the compositions known up to the present. Factors never heretofore included in oral endoparasiticide compositions based on doramectin, presenting a wide differential advantage compared with the compositions known up to the present. These and other characteristics, objectives and advantages of the present invention will be appreciated by those skilled in the art from the detailed description provided below in the present document, together with the attached claims. |
| priorityDate | 2008-09-19-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| type | http://data.epo.org/linked-data/def/patent/Publication |
Incoming Links
Total number of triples: 32.